Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Building and Managing a Patent Portfolio to Best Support your Business Training Course (May 11, 2026)" has been added to ResearchAndMarkets.com's...
-
LOS ANGELES, Jan. 15, 2026 (GLOBE NEWSWIRE) -- GBT Technologies, Inc. (OTC: GTCH) (“GBT” or the “Company”), a technology developer specializing in AI, IoT, and integrated system architectures, today...
-
ENGLEWOOD, Colo., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels and chemicals, as well as carbon management, today announced that it has been awarded U.S....
-
SciSparc intends to commence commercialization of these patented technologies immediately following the transaction closing TEL AVIV, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd....
-
TEL AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage...
-
Press Release
-
DOVER, USA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) (“Sunrise” or the “Company”) today announced that its subsidiary, Sunrise (Guizhou) New Energy Materials...
-
DOVER, USA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) (“Sunrise” or the “Company”) today announced that its subsidiary, Sunrise (Guizhou) New Energy Materials...
-
These patents represent a significant turning point for Propanc and commercial potential of PRP for treating chronic diseases such as cancer and fibrosis
-
TEL AVIV, Israel, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a company engaged in clinical-stage pharmaceutical developments through its...